Literature DB >> 17710395

PET-CT enteroclysis: a new technique for evaluation of inflammatory diseases of the intestine.

Chandan Jyoti Das1, Govind Makharia, Rakesh Kumar, Madhavi Chawla, Pooja Goswami, Raju Sharma, Arun Malhotra.   

Abstract

PURPOSE: While CT/MR enteroclysis provides excellent anatomical details, it fails to provide information on metabolic activity of the inflammatory lesions of the intestine. We conceptualized a fusion of metabolic imaging techniques such as PET and an anatomical imaging modality such as CT enteroclysis to derive information both on morphological details and functional activity of lesions at the same time. PATIENTS AND METHODS: In a prospective study, we included 17 adult patients with newly diagnosed inflammatory diseases of the intestine. Low dose whole body PET-CT scan was obtained first, which began at approximately 60 min after injection of 10 mCi of (18)fluoro-deoxyglucose (FDG). Subsequently, PET-CT enteroclysis of the abdomen was performed after infusion of 2 l of 0.5% methylcellulose through a naso-jejunal catheter.
RESULTS: Fourteen patients had abnormal and three had normal PET-CT enteroclysis studies. Twenty-three segments of small intestine and 27 segments of large intestine showed increased FDG uptake. The detection rate of PET-CT enteroclysis was significantly higher (total =50 segments, 23 segments of small intestine and 27 segments of large intestine) as compared with barium studies (16 segments of small intestine) and colonoscopy (17 segments of large intestine) combined together (total =33 segments). In addition PET-CT enteroclysis showed extra-luminal FDG uptake (lymph nodes in two, sacroilitis in two, and mesenteric fat proliferation in five).
CONCLUSIONS: As a single investigation, PET-CT enteroclysis detects a significantly higher number of lesions both in the small and large intestine in comparison to that detected by conventional barium and colonoscopy combined together. This technique is non-invasive, feasible and very promising.

Entities:  

Mesh:

Year:  2007        PMID: 17710395     DOI: 10.1007/s00259-007-0525-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  34 in total

1.  Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease.

Authors:  E Lantto; K Järvi; I Krekelä; T Lantto; M Taavitsainen; H Vedenkangas; M Vorne
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  New diagnostic imaging tools for inflammatory bowel disease.

Authors:  B A Mackalski; C N Bernstein
Journal:  Gut       Date:  2006-05       Impact factor: 23.059

3.  Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer.

Authors:  Jong-Ho Kim; Johannes Czernin; Martin S Allen-Auerbach; Benjamin S Halpern; Barbara J Fueger; Joel R Hecht; Osman Ratib; Michael E Phelps; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2005-04       Impact factor: 10.057

4.  Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.

Authors:  H Abdel-Nabi; R J Doerr; D M Lamonica; V R Cronin; P J Galantowicz; G M Carbone; M B Spaulding
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

5.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 6.  Bowel hot spots at PET-CT.

Authors:  Hima B Prabhakar; Dushyant V Sahani; Alan J Fischman; Peter R Mueller; Michael A Blake
Journal:  Radiographics       Date:  2007 Jan-Feb       Impact factor: 5.333

Review 7.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Authors:  Hongming Zhuang; Abass Alavi
Journal:  Semin Nucl Med       Date:  2002-01       Impact factor: 4.446

8.  Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET.

Authors:  Neeta Pandit-Taskar; Heiko Schöder; Mithat Gonen; Steven M Larson; Henry W D Yeung
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

9.  Multidetector CT enteroclysis versus barium enteroclysis with methylcellulose in patients with suspected small bowel disease.

Authors:  Laura Maria Minordi; Amorino Vecchioli; Luisa Guidi; Paoletta Mirk; Luisa Fiorentini; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2006-03-22       Impact factor: 5.315

10.  Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance.

Authors:  G Sciarretta; A Furno; M Mazzoni; C Basile; P Malaguti
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

View more
  7 in total

Review 1.  Utility of positron emission tomography/CT in the evaluation of small bowel pathology.

Authors:  C G Cronin; J Scott; A Kambadakone; O A Catalano; D Sahani; M A Blake; S McDermott
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

2.  Toward Molecular Imaging of Intestinal Pathology.

Authors:  Mariane Le Fur; Iris Y Zhou; Onofrio Catalano; Peter Caravan
Journal:  Inflamm Bowel Dis       Date:  2020-09-18       Impact factor: 5.325

3.  PET/CT colonography: a novel non-invasive technique for assessment of extent and activity of ulcerative colitis.

Authors:  Chandan J Das; Govind K Makharia; Rakesh Kumar; Rajender Kumar; Rajeew P Tiwari; Raju Sharma; Arun Malhotra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-22       Impact factor: 9.236

4.  Carcinoma of unknown primary of neuroendocrine origin: Accurate detection of primary with (68)Ga-labelled [1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid]-1-NaI3-Octreotide positron emission tomography/computed tomography enterography.

Authors:  Tarun Kumar Jain; Sellam Karunanithi; Varun Singh Dhull; Shambo Guha Roy; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2014-04

5.  Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art.

Authors:  Federico Caobelli; Laura Evangelista; Natale Quartuccio; Demetrio Familiari; Corinna Altini; Angelo Castello; Mariapaola Cucinotta; Rossella Di Dato; Cristina Ferrari; Aurora Kokomani; Iashar Laghai; Riccardo Laudicella; Silvia Migliari; Federica Orsini; Salvatore Antonio Pignata; Cristina Popescu; Erinda Puta; Martina Ricci; Silvia Seghezzi; Alessandro Sindoni; Martina Sollini; Letterio Sturiale; Anna Svyridenka; Vittoria Vergura; Pierpaolo Alongi
Journal:  World J Radiol       Date:  2016-10-28

6.  Unsuspected Active Ulcerative Colitis in a Patient With Dermatomyositis: A Rare Association Detected on 18F-FDG PET/CT During the Search for an Occult Malignancy.

Authors:  Sampanna Jung Rayamajhi; Arun Kumar Reddy Gorla; Rajender Kumar Basher; Ashwani Sood; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2017 Apr-Jun

Review 7.  Imaging Inflammation and Infection in the Gastrointestinal Tract.

Authors:  Alex N Frickenstein; Meredith A Jones; Bahareh Behkam; Lacey R McNally
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.